Jennifer Myers, in Bel Aire, KS - Marriage & Family Therapist

Jennifer Myers, is a Marriage & Family Therapist based in Bel Aire, Kansas. Jennifer Myers is licensed to practice in * (Not Available) (license number ) and her current practice location is 4230 N Stratford Ln, Bel Aire, Kansas. She can be reached at her office (for appointments etc.) via phone at (316) 461-3816.

NPI number for Jennifer Myers is 1528707866 and her current mailing address is 4230 N Stratford Ln, Bel Aire, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1528707866.

Contact Information

	Jennifer Myers,
	4230 N Stratford Ln, Bel Aire, KS 67226-1400
	(316) 461-3816
	Not Available

Healthcare Provider's Profile

Full Name	Jennifer Myers
Gender	Female
Speciality	Marriage & Family Therapist
Location	4230 N Stratford Ln, Bel Aire, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1528707866
Provider Enumeration Date: 06/03/2022
Last Update Date: 06/03/2022

Medical Identifiers

Medical identifiers for Jennifer Myers such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1528707866	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jennifer Myers is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jennifer Myers, 4230 N Stratford Ln, Bel Aire, KS 67226-1400 Ph: () -	Jennifer Myers, 4230 N Stratford Ln, Bel Aire, KS 67226-1400 Ph: (316) 461-3816

News Archive

Sundia MediTech and Xcovery announce new drug discovery

Sundia MediTech, a CRO company based in Shanghai, China and Xcovery, a company based in Florida, U.S.A. jointly announced their 2 year collaborative success in new drug discovery at IBC's BioProcess International Conference yesterday in San Diego, USA.

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.

The Endocrine Society recommends avoiding hormone therapy for transgender children before puberty

A custody case in Texas has sparked heated debate and embroiled state policymakers in public discussions about the diagnosis and appropriate medical treatment of transgender children.

USPTO issues a Notice of Allowance for Milestone's drug delivery system patent application

Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Milestone's U.S. patent application, titled "Computer Controlled Drug Delivery System with Dynamic Pressure Sensing."

Jennifer Myers, - Couples Therapy in Bel Aire, KS